Assess the relationship between vascular FDG-PET activity and clinical assessments in giant cell arteritis.
Conducted a randomized controlled trial
Utilized FDG-PET imaging for vascular assessment
Evaluated discordance between imaging and clinical findings
Identified instances where FDG-PET activity did not match clinical assessments
Indicated a need for further exploration of imaging outcomes in trials
Abstract
Vascular FDG-PET activity may be discordant with clinical assessment, particularly in subsets of patients with GCA. Imaging-based outcome measures should remain exploratory in future therapeutic trials.
AIに質問
Like
Bookmark
Share
View Full Paper
AIに質問
Like
Bookmark
Share
View Full Paper
18F‐Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment within a Randomized Controlled Trial in Giant Cell Arteritis | Synapse